BRK1 anticorps (Middle Region)
Aperçu rapide pour BRK1 anticorps (Middle Region) (ABIN629872)
Antigène
Voir toutes BRK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- C3 ORF10 antibody was raised against the middle region of C3 rf10
-
Purification
- Purified
-
Immunogène
- C3 ORF10 antibody was raised using the middle region of C3 rf10 corresponding to a region with amino acids YIEIITSSIKKIADFLNSFDMSCRSRLATLNEKLTALERRIEYIEARVTK
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C3ORF10 Blocking Peptide, (ABIN936099), is also available for use as a blocking control in assays to test for specificity of this C3ORF10 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C0 RF10 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BRK1 (BRICK1, SCAR/WAVE Actin-Nucleating Complex Subunit (BRK1))
-
Autre désignation
- C3ORF10
-
Sujet
- C3orf10 is involved in regulation of actin and microtubule organization. It is a part of a WAVE complex that activates the Arp2/3 complex.
-
Poids moléculaire
- 9 kDa (MW of target protein)
-
Pathways
- Signalisation RTK
Antigène
-